Answers are grounded in this paper and cite their sources.
Accelerated titration (i.e., rapid intrapatient drug dose escalation) designs appear to effectively reduce the number of patients who are under-treated, speed the completion of phase I trials, and provide a substantial increase in the information obtained.
No takes yet. Share an insight, caveat, or question.
Simon et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: